Diagnosis and treatment of bone metastasis: comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, Japanese Urological Association, and Japanese Society for Radiation Oncology
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Diagnosis and treatment of bone metastasis requires various types of measures, specialists and caregivers. To provide better diagnosis and treatment, a multidisciplinary team approach is required. The members of this multidisciplinary team include doctors of primary cancers, radiologists, pathologists, orthopaedists, radiotherapists, clinical oncologists, palliative caregivers, rehabilitation doctors, dentists, nurses, pharmacists, physical therapists, occupational therapists, medical social workers, etc. Medical evidence was extracted from published articles describing meta-analyses or randomised controlled trials concerning patients with bone metastases mainly from 2003 to 2013, and a guideline was developed according to the Medical Information Network Distribution Service Handbook for Clinical Practice Guideline Development 2014. Multidisciplinary team meetings are helpful in diagnosis and treatment. Clinical benefits such as physical or psychological palliation obtained using the multidisciplinary team approaches are apparent. We established a guideline describing each specialty field, to improve understanding of the different fields among the specialists, who can further provide appropriate treatment, and to improve patients' outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
Tannock, I. F., de Wit, R., Berry, W. R., Horti, J., Pluzanska, A., Chi, K. N., Oudard, S., Théodore, C., James, N. D., Turesson, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040720 · Cited by 5,735 · cited 1×
“Prostate cancer is sensitive to hormonal treatment in the first 2 years on average, but finally turns into castration-resistant prostate cancer (CRPC).(65) 66 Clodronate combined with hormonal treatment”
BackgroundAlpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
Parker, C., Nilsson, S., Heinrich, D., Helle, S. I., O'Sullivan, J. M., Fosså, S. D., Chodacki, A., Wiechno, P., Logue, J., Seke, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213755 · Cited by 3,408
Allemani, C., Weir, H. K., Carreira, H., Harewood, R., Spika, D., Wang, X.-S., Bannon, F., Ahn, J. V., Johnson, C. J., Bonaventure, A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62038-9 · Cited by 2,614 · cited 1×
“many countries, the 5-year survival rate for prostate cancer is ≥95%.(1) An increase in the survival time may increase the incidence of”
BackgroundPertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
Swain, S. M., Baselga, J., Kim, S.-B., Ro, J., Semiglazov, V., Campone, M., Ciruelos, E., Ferrero, J.-M., Schneeweiss, A., Heeson, S., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1413513 · Cited by 2,164
Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
San Miguel, J. F., Schlag, R., Khuageva, N. K., Dimopoulos, M. A., Shpilberg, O., Kropff, M., Spicka, I., Petrucci, M. T., Palumbo, A., Samoilova, O. S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801479 · Cited by 1,899
Rosen, L. S., Gordon, D., Tchekmedyian, N. S., Yanagihara, R., Hirsh, V., Krzakowski, M., Pawlicki, M., de Souza, P., Zheng, M., Urbanowitz, G., et al. (2004) · Cancer · doi:10.1002/cncr.20308 · Cited by 705 · cited 1×
“5%.(6) 51 52 61 69 90–93 However, many of these toxicities remain within grade 1 or 2 and are reversible.”
BackgroundScagliotti, G. V., Hirsh, V., Siena, S., Henry, D. H., Woll, P. J., Manegold, C., Solal-Celigny, P., Rodriguez, G., Krzakowski, M., Mehta, N. D., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31826aec2b · Cited by 335 · cited 1×
“Exploratory analysis of this trial indicated that OS was prolonged in the D-mab group.(54)”
ResultMiaskowski, C., Dodd, M., West, C., Schumacher, K., Paul, S. M., Tripathy, D., & Koo, P. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.140 · Cited by 240
Bisphosphonates in multiple myeloma: a network meta-analysis
Mhaskar, R., Redzepovic, J., Wheatley, K., Clark, O. A. C., Miladinovic, B., Glasmacher, A., Kumar, A., & Djulbegovic, B. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003188.pub3 · Cited by 130
Cited by
A systematic review of rehabilitation and exercise recommendations in oncology guidelines
Stout, N. L., Santa Mina, D., Lyons, K. D., Robb, K., & Silver, J. K. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21639 · Cited by 286
Minimally invasive interventional procedures for metastatic bone disease: A comprehensive review
Papalexis, N., Parmeggiani, A., Peta, G., Spinnato, P., Miceli, M., & Facchini, G. (2022) · Current Oncology · doi:10.3390/curroncol29060332 · Cited by 29
Yamamichi, G., Kato, T., Arakawa, N., Ino, Y., Ujike, T., Nakano, K., Koh, Y., Motoyama, Y., Outani, H., Myoba, S., et al. (2024) · Biomarker Research · doi:10.1186/s40364-024-00695-6 · Cited by 13
Yamamichi, G., Kato, T., Arakawa, N., Ino, Y., Ujike, T., Nakano, K., Koh, Y., Motoyama, Y., Outani, H., Myoba, S., et al. (2024) · doi:10.21203/rs.3.rs-4834587/v1
Metadata
- Authors
- Shibata, H., Kato, S., Sekine, I., Abe, K., Araki, N., Iguchi, H., Izumi, T., Inaba, Y., Osaka, I., Kato, S., Kawai, A., Kinuya, S., Kodaira, M., Kobayashi, E., Kobayashi, T., Sato, J., Shinohara, N., Takahashi, S., Takamatsu, Y., Takayama, K., Takayama, K., Tateishi, U., Nagakura, H., Hosaka, M., Morioka, H., Moriya, T., Yuasa, T., Yurikusa, T., Yomiya, K., & Yoshida, M.
- Venue
- ESMO Open
- Publisher
- Elsevier BV
- Published
- 2016
- Volume
- 1
- Issue
- 2
- Pages
- e000037
- ISSN
- 2059-7029 (ISSN-L)
- OpenAlex
- W2330933064
- Cited by
- 97
- References
- 9
- FWCI
- 7.30
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diagnosis and treatment of bone metastasis: comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, Japanese Urological Association, and Japanese Society for Radiation Oncology. https://app.cochat.ai/papers/10.1136/esmoopen-2016-000037
- The paper
- Shibata, H., Kato, S., Sekine, I., Abe, K., Araki, N., Iguchi, H., Izumi, T., Inaba, Y., Osaka, I., Kato, S., Kawai, A., Kinuya, S., Kodaira, M., Kobayashi, E., Kobayashi, T., Sato, J., Shinohara, N., Takahashi, S., Takamatsu, Y., . . . Yoshida, M. (2016). Diagnosis and treatment of bone metastasis: comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, Japanese Urological Association, and Japanese Society for Radiation Oncology. ESMO Open. https://doi.org/10.1136/esmoopen-2016-000037
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.